Becton, Dickinson and Company (BDX) Given Average Rating of "Buy" by Brokerages


When we look at the Volatility of the company, Week Volatility is at 2.66% whereas Month Volatility is at 2.09%. (NYSE:BDX) during the second quarter, Holdings Channel reports.

Other institutional investors have also modified their holdings of the company. State Board of Administration of Florida Retirement System now owns 315,591 shares of the medical instruments supplier's stock valued at $61,840,000 after buying an additional 2,650 shares in the last quarter. The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. Finally, Financial Architects Inc increased its holdings in shares of Becton, Dickinson and by 8.0% in the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier's stock worth $135,000 after acquiring an additional 221 shares during the period. Almanack Investment Partners LLC. purchased a new stake in shares of Becton, Dickinson and in the 1st quarter worth $105,000. In the last earnings report the EPS was $3.45 and is expected to be $9.46 for the current year with 227,564,000 shares outstanding. Following the completion of the sale, the insider now owns 95,781 shares of the company's stock, valued at $19,517,294.37. Alpine Investment Management Llc sold 25,978 shares as the company's stock declined 6.04% while stock markets rallied. The firm has "Buy" rating by UBS given on Friday, February 5. The stock was sold at an average price of $197.41, for a total transaction of $1,178,735.11. The hedge fund held 685,913 shares of the major banks company at the end of 2017Q2, valued at $62.69 million, down from 711,891 at the end of the previous reported quarter. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The ex-dividend date was set for Thursday the 7th of September 2017.

Other institutional investors have also recently bought and sold shares of the company. The disclosure for this sale can be found here. Its last month's stock price volatility remained 0.94% which for the week approaches 1.23%. Insiders own 1.40% of the company's stock.

Becton, Dickinson and (NYSE BDX) opened at 208.67 on Wednesday.

The Amalgamated Bank Buys New Position in Papa John's International Inc. (PZZA)
News stories about Papa John's International (NASDAQ: PZZA ) have trended somewhat positive on Wednesday, Accern reports. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

The market cap of 47.75B for Becton, Dickinson and Company in today's market indicated its current strength, making the company's shares a lucrative one. Becker Capital Management Inc sold 2,165 shares as Becton Dickinson & Company (BDX)'s stock rose 1.79%.

After a recent look, shares have been seen 9.21% from the 200-day moving average, and 4.22% from the 50-day moving average. The company had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. The Return on Investment and Return on Equity (ROE) values are 6.6 percent and 8.5 percent, respectively. The firm's revenue for the quarter was down 5.1% on a year-over-year basis. During the same period a year ago, the firm earned $2.35 earnings per share. As of the end of the quarter Baskin Financial Services Inc. had acquired a total of 1,504 shares growing its stake by 4.0%. If you are reading this news story on another publication, it was copied illegally and republished in violation of global copyright law.

BDX has been the topic of several research reports. More interesting news about Becton Dickinson and Co (NYSE:BDX) were released by: and their article: "Buy Rating on Becton Dickinson & Co (BDX) Shares Kept" published on October 10, 2017 as well as's news article titled: "Eastern District Court Denies Motion to Reconsider Becton, Dickinson and Co ..." with publication date: October 31, 2017. Deutsche Bank maintained the stock with "Hold" rating in Monday, August 10 report. Bank of America Corporation restated a "buy" rating and issued a $225.00 target price (up from $200.00) on shares of Becton, Dickinson and in a research note on Friday, July 21st. Analysts have placed a $57 price target on, Inc., suggesting a 29.69% gain from recent close. Finally, BidaskClub upgraded Becton, Dickinson and from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, July 11th. Zacks Investment Research raised shares of Becton, Dickinson and from a "hold" rating to a "buy" rating and set a $234.00 price objective on the stock in a report on Tuesday. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. It is positive, as 50 investors sold BDX shares while 311 reduced holdings.